Page 1 of 1
| Politician | Branch | Asset | Ticker | Category | Type | Transaction Date | Amount | Filing Date |
|---|---|---|---|---|---|---|---|---|
| Donald J Trump | executive | ADNI FC REIT CL A | ADNI | REAL ESTATE | purchase | Feb. 12, 2026 | $$100,001 - $250,000 | May 14, 2026 |
| Donald J Trump | executive | ADN PLC SHS CL A | ADN | STOCK | purchase | Jan. 6, 2026 | $$100,001 - $250,000 | May 14, 2026 |
| Michael T. McCaul | house | ADN PLC-CLASS A | ADN | STOCK | Purchase | Aug. 21, 2025 | $$1,000-$15,000 | Sept. 11, 2025 |
| Michael T. McCaul | house | ADN PLC | ADN | STOCK | PURCHASE | Aug. 26, 2024 | $$1,001-5,000 | Sept. 16, 2024 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | Sale | Nov. 17, 2016 | $$15,001 - $50,000 | Dec. 2, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | Sale | Nov. 17, 2016 | $$1,001 - $15,000 | Dec. 2, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | Sale | Nov. 17, 2016 | $$1,001 - $15,000 | Dec. 2, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | Sale | Nov. 1, 2016 | $$1,001 - $15,000 | Dec. 2, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | E | Oct. 31, 2016 | $$1,001 - $15,000 | Nov. 7, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | E | Oct. 31, 2016 | $$1,001 - $15,000 | Nov. 7, 2016 |
| Thomas MacArthur | house | Adient plc ordinary Shares (ADNT) | ADNT | STOCK | E | Oct. 31, 2016 | $$15,001 - $50,000 | Nov. 7, 2016 |
| Michael T. McCaul | house | ALDENON PHARMACEUTICALS INC | ADNP | STOCK | PURCHASE | June 14, 2016 | $$1,000-$10,000 | July 15, 2016 |
| Michael T. McCaul | house | ADN PLC | ADN | STOCK | PURCHASE | May 6, 2016 | $$100,001-$250,000 | June 16, 2016 |
| Michael T. McCaul | house | KADANY INC | KADNY | STOCK | PURCHASE | Feb. 19, 2016 | $nan | March 18, 2016 |
| James B. Renacci | house | AZURED BIOTECH INCORPORATED (ADNB) | ADNB | STOCK | PURCHASE | Jan. 22, 2016 | $$1,000 - $15,000 | Feb. 8, 2016 |
| James B. Renacci | house | ADN PLC SIG CL A (UNITED KINGDOM) | ADN | STOCK | PURCHASE | Aug. 25, 2014 | $$1,000-$15,000 | Aug. 22, 2014 |
| James B. Renacci | house | ADN PLC SHS CL A (UNITED KINGDOM) | ADN | STOCK | SALE | Aug. 15, 2014 | $$1,000-$15,000 | Aug. 22, 2014 |
| James B. Renacci | house | ADN PLC SNS CL (UNITED KINGDOM) (ADN) | ADN | STOCK | PURCHASE | Aug. 13, 2014 | $$15,001 - $50,000 | Aug. 22, 2014 |
| James B. Renacci | house | ADN PLC SHS CL A (UNITED KINGDOM) (ADN) | ADN | STOCK | PURCHASE | Aug. 7, 2014 | $$1,000 - $15,000 | Aug. 22, 2014 |
| James B. Renacci | house | ADN PLC SHS CL A (UNITED KINGDOM) (ADN) | ADN | STOCK | PURCHASE | Aug. 6, 2014 | $$1,000 - $15,000 | Aug. 22, 2014 |
| James B. Renacci | house | ALEXON PHARMACEUTICALS INCORPORATED (ADNP) | ADNP | STOCK | PURCHASE | April 25, 2014 | $$50,001 - $100,000 | May 2, 2014 |
| Michael T. McCaul | house | ADN PLC | ADN | STOCK | Purchase | Nov. 19, 2004 | $$1,000-$15,000 | Dec. 16, 2024 |